Key result
Elevated NLR is linked to higher major cardiovascular events post-PCI, reaching ~16% in patients with diabetes.
Why the study?
Limited evidence exists regarding the prognostic role of neutrophil-to-lymphocyte ratio in patients with diabetes mellitus undergoing PCI.
Does an elevated neutrophil-to-lymphocyte ratio predict major adverse cardiovascular events in patients with and without diabetes mellitus undergoing percutaneous coronary intervention?
Cohort (n=9,427)
No
Does an elevated neutrophil-to-lymphocyte ratio predict major adverse cardiovascular events in patients with and without diabetes mellitus undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Elevated neutrophil-to-lymphocyte ratio is an independent predictor of adverse cardiovascular outcomes in patients undergoing PCI, with the highest risk observed in those with concomitant diabetes mellitus.
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with adverse cardiovascular outcomes. However, limited evidence exists regarding its prognostic role in patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI), which we sought to explore in this analysis. METHODS: We retrospectively evaluated all patients undergoing PCI at a large tertiary centre between 2012 and 2022. Patients were stratified according to the presence of DM, and NLR quartiles were derived in each subgroup. The primary endpoint was major adverse cardiovascular events (MACE), consisting of all-cause mortality, spontaneous myocardial infarction (MI) or stroke. Secondary endpoints were each single MACE component, target vessel revascularisation, bleeding and postprocedural acute kidney injury. A multivariable Cox regression model, adjusted for relevant baseline characteristics, was computed. RESULTS: A total of 9427 patients were included (48.5% with DM). DM patients had more comorbidities and higher baseline high-sensitivity C reactive protein levels, while patients with elevated NLR in both subgroups exhibited multivessel disease with moderate/severe calcification. DM patients in the upper NLR quartile had the highest rates of MACE (15.7%) than any other subgroup. An independent association of elevated NLR with MACE was observed in both patients with and without DM, and was confirmed after multivariable adjustment. This was primarily driven by all-cause mortality rates in both subgroups and by MI incidence in DM patients only. CONCLUSIONS: Patients undergoing PCI with a higher NLR had worse clinical outcomes, regardless of DM status. The combination of DM and elevated NLR revealed the most unfavourable prognosis.
No takes yet. Share an insight, caveat, or question.
Muro et al. (2025) conducted a cohort in Patients undergoing percutaneous coronary intervention (n=9,427). Elevated neutrophil-to-lymphocyte ratio (NLR) vs. Lower neutrophil-to-lymphocyte ratio was evaluated on Major adverse cardiovascular events (MACE), consisting of all-cause mortality, spontaneous myocardial infarction (MI) or stroke. Elevated neutrophil-to-lymphocyte ratio was independently associated with major adverse cardiovascular events in patients undergoing PCI, peaking at a 15.7% major cardiovascular events rate in patients with diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: